An overview of the significance of troponin in acute myocardial infarction
Year: 2015
Type: article
Abstract: Biomarkers are helpful tests for making a diagnosis. They are usually the golden standard for their respective diseases. Cardiology, especially, uses biomarkers extensively. Because a great margin of cardiologic emergencies present with a risk of mortality; swift diagnosis and treatment is essential. Biomarkers are helpful in the manner that they shorten diagnosis time. Acute Myocardial Infarction (AMI) is one of the most frequent cardiological emergencies. When it is taken into account that AMI presents with vital risk and that the outcome is dependent on swift diagnosis and treatment speed; it is obvious that it is of utmost importance to have a biomarker that defines the diagnosis with certainty. Cardiac troponin harbors these qualities and is accepted as the fundamental factor for diagnosis and prognosis. This review summarizes the start of biomarker research for AMI until the discovery of troponin, emphasizes troponin’s usage today and provides possible ideas for future enhancement.
Source: Acta Medica
Authors: Ahmet Yalçınkaya, Yeşim Öztaş
Institution: Hacettepe University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2184240896